BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35044951)

  • 1. EBV Plasma Epstein-Barr Virus (EBV) DNA as a Biomarker for Diagnosis of EBV-positive Hodgkin Lymphoma in Syria.
    Habeeb R; Al Hafar L; Monem F
    J Infect Dev Ctries; 2021 Dec; 15(12):1917-1922. PubMed ID: 35044951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Epstein Barr virus (EBV) DNA as a biomarker for EBV associated Hodgkin lymphoma.
    Dinand V; Sachdeva A; Datta S; Bhalla S; Kalra M; Wattal C; Radhakrishnan N
    Indian Pediatr; 2015 Aug; 52(8):681-5. PubMed ID: 26388626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Epstein Barr viral load in adult-onset Hodgkin lymphoma in South India.
    Sinha M; Rao CR; Shafiulla M; Shankaranand B; Viveka BK; Lakshmaiah KC; Jacob LA; Babu GK; Jayshree RS
    Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):8-13. PubMed ID: 26657995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.
    Gandhi MK; Lambley E; Burrows J; Dua U; Elliott S; Shaw PJ; Prince HM; Wolf M; Clarke K; Underhill C; Mills T; Mollee P; Gill D; Marlton P; Seymour JF; Khanna R
    Clin Cancer Res; 2006 Jan; 12(2):460-4. PubMed ID: 16428487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
    Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
    APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
    de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
    HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free epstein-barr viral loads in childhood hodgkin lymphoma: a study from South India.
    Sinha M; Rao CR; Shafiulla M; Appaji L; Bs AK; Sumati BG; Avinash T; Jayshree RS
    Pediatr Hematol Oncol; 2013 Sep; 30(6):537-43. PubMed ID: 23756088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of free circulating Epstein-Barr virus DNA in plasma of patients with Hodgkin's disease.
    Musacchio JG; Carvalho Mda G; Morais JC; Silva NH; Scheliga A; Romano S; Spector N
    Sao Paulo Med J; 2006 May; 124(3):154-7. PubMed ID: 17119693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of quantitative analysis of plasma epstein- barr virus DNA in patients of Xinjiang Uygur nationality with Hodgkin's Lymphoma.
    Li X; Yang SE; Guo YQ; Shen MX; Gu L; Zhao GB; Liu W; Xun T; Bai JP
    Asian Pac J Cancer Prev; 2012; 13(12):6379-84. PubMed ID: 23464462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Epstein-Barr virus DNA in peripheral blood of paediatric patients with Hodgkin's disease by real-time polymerase chain reaction.
    Wagner HJ; Schläger F; Claviez A; Bucsky P
    Eur J Cancer; 2001 Oct; 37(15):1853-7. PubMed ID: 11576839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies.
    Lei KI; Chan LY; Chan WY; Johnson PJ; Lo YM
    Br J Haematol; 2000 Oct; 111(1):239-46. PubMed ID: 11091207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study.
    Westmoreland KD; Stanley CC; Montgomery ND; Kaimila B; Kasonkanji E; El-Mallawany NK; Wasswa P; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Chikasema M; Makwakwa V; Kampani C; Dhungel BM; Sanders MK; Krysiak R; Tomoka T; Liomba NG; Dittmer DP; Fedoriw Y; Gopal S
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27781380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era.
    Lupo J; Germi R; Lancar R; Algarte-Genin M; Hendel-Chavez H; Taoufik Y; Mounier N; Partisani M; Bonnet F; Meyohas MC; Marchou B; Semanova T; Prevot S; Costagliola D; Morand P; Besson C
    AIDS; 2019 May; 33(6):993-1000. PubMed ID: 30946153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of EBV infection in lymphomas diagnosed in Lusaka, Zambia.
    Kafita D; Kaile T; Malyangu E; Tembo R; Zulu E; Chisanga C; Kalonda A; Samutela M; Polepole P; Kwenda G
    Pan Afr Med J; 2018; 29():181. PubMed ID: 30061959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group.
    Shen Z; Hu L; Yao M; He C; Liu Q; Wang F; Gu W; Wang Y; Dong M; Zhu T; Yin T; Li F; Jin Y; Huang S; Zhang H; Sang W;
    Int J Cancer; 2022 Jan; 150(2):327-334. PubMed ID: 34520566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three methods for the detection of Epstein-Barr virus in Hodgkin's lymphoma in paraffin-embedded tissues.
    Qi ZL; Han XQ; Hu J; Wang GH; Gao JW; Wang X; Liang DY
    Mol Med Rep; 2013 Jan; 7(1):89-92. PubMed ID: 23128841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma.
    Park JH; Yoon DH; Kim S; Park JS; Park CS; Sung H; Lee SW; Huh J; Suh C
    Ann Hematol; 2016 Apr; 95(5):801-8. PubMed ID: 26883027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of Epstein-Barr virus in different types of lymphoma.
    Shaklawoon K; Altagazi N; Altorjman F; Alturki A; Eltaweel M; Alqawi O
    Mol Biol Rep; 2020 Mar; 47(3):1803-1807. PubMed ID: 31993862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Epstein-Barr virus association with pediatric non-hodgkin lymphoma in immunocompetent and in immunocompromised patients in Argentina.
    Chabay PA; De Matteo EN; Aversa L; Maglio S; Grinstein S; Preciado MV
    Arch Pathol Lab Med; 2002 Mar; 126(3):331-5. PubMed ID: 11860309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Role of the Expression of Latent-Membrane Protein 1 of Epstein-Barr Virus in Classical Hodgkin Lymphoma.
    Santisteban-Espejo A; Perez-Requena J; Atienza-Cuevas L; Moran-Sanchez J; Fernandez-Valle MDC; Bernal-Florindo I; Romero-Garcia R; Garcia-Rojo M
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.